Donald L Lappe
Overview
Explore the profile of Donald L Lappe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
1982
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anderson J, Knowlton K, May H, Le V, Lappe D, Cripps S, et al.
JACC Adv
. 2024 Jun;
2(10):100676.
PMID: 38938499
Background: Statins can improve outcomes in high-risk primary prevention populations. However, application in clinical practice has lagged. Objectives: The objective of this study was to compare an active vs a...
2.
Muhlestein J, Kammerer J, Bair T, Knowlton K, Le V, Anderson J, et al.
BMC Prim Care
. 2022 Apr;
23(1):65.
PMID: 35365076
Background: Hyperkalaemia (HK) is a serious and potentially life-threatening condition. Both acute and chronic conditions may alter potassium homeostasis. Our aim is to describe HK incidence, clinical outcomes, and associated...
3.
Muhlestein J, Knowlton K, Le V, Lappe D, May H, Min D, et al.
JACC Cardiovasc Imaging
. 2021 Dec;
15(5):843-855.
PMID: 34922872
Objectives: This study sought to determine the feasibility of performing an extensive randomized outcomes trial comparing a coronary artery calcium (CAC)- versus a pooled cohort equations (PCE) risk score-based strategy...
4.
Horne B, Muhlestein J, Lappe D, May H, Le V, Bair T, et al.
Am Heart J
. 2021 Nov;
244:125-134.
PMID: 34798073
Background: Medication adherence is generally low and challenging to address because patient actions control healthcare delivery outside of medical environments. Behavioral nudging changes clinician behavior, but nudging patient decision-making requires...
5.
May H, Knowlton K, Anderson J, Lappe D, Bair T, Muhlestein J
Eur Heart J Qual Care Clin Outcomes
. 2021 Mar;
8(3):352-360.
PMID: 33787865
Aims: Despite proven benefits of LDL-C lowering among those with atherosclerotic cardiovascular disease (ASCVD), statin adherence remains low. Very little real-world data exist on the effect of long-term statin adherence...
6.
Barker T, May H, Doty J, Lappe D, Knowlton K, Carlquist J, et al.
Physiol Rep
. 2021 Feb;
9(3):e14747.
PMID: 33580636
Low vitamin D (serum or plasma 25-hydroxyvitamin D (25(OH)D)) is a global pandemic and associates with a greater prevalence in all-cause and cardiovascular mortality and morbidity. Open-heart surgery is a...
7.
Muhlestein J, Kammerer J, Bair T, Knowlton K, Le V, Anderson J, et al.
ESC Heart Fail
. 2020 Dec;
8(1):691-696.
PMID: 33331114
Aims: This analysis qualitatively describes the impact of hyperkalaemia (HK) and renin-angiotensin-aldosterone system inhibitor (RAASi) use on clinical outcomes in patients with heart failure (HF). Methods And Results: Patients were...
8.
Bair T, May H, Knowlton K, Anderson J, Lappe D, Muhlestein J
J Cardiovasc Pharmacol
. 2020 Feb;
75(5):426-431.
PMID: 32079856
Statins are among the most prescribed medications because of the well-documented benefits of safely lowering low-density lipoprotein cholesterol. However, many patients are unable or unwilling to continue statin therapy because...
9.
Le V, Knight S, Min D, McCubrey R, Horne B, Jensen K, et al.
Circ Cardiovasc Imaging
. 2020 Jan;
13(1):e009907.
PMID: 31959008
Background: Myocardial perfusion imaging, including positron emission tomography/computed tomography (PET/CT), is often used to assess for high-grade coronary artery disease (CAD) requiring revascularization. The use of coronary artery calcium (CAC)...
10.
Anderson J, Le V, Min D, Biswas S, Minder C, McCubrey R, et al.
Am J Cardiol
. 2019 Dec;
125(3):341-348.
PMID: 31806210
Atherosclerotic cardiovascular disease (ASCVD) is the most important cause of morbidity and mortality nationally and internationally. Improving ASCVD risk prediction is a high clinical priority. We sought to determine which...